Feed Preview

miRNAs in Cardiovascular Biology

miRNAs in Cardiovascular Biology diagram by vetpathologist, Shutterstock
vetpathologist, Shutterstock

MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression through inhibition of protein translation or by degradation of specific transcripts. miRNAs can regulate cardiovascular health, and be potential biomarkers or targets in cardiovascular disease. Discover the latest research on miRNAs in Cardiovascular Biology here.

Top 20 most recent papers
Trends in Cardiovascular Medicine

Most important advances in preventive cardiology during this past decade: Viewpoint from the American Society for Preventive Cardiology

Trends in Cardiovascular MedicineDecember 29, 2019
Nathan D WongAmerican Society for Preventive Cardiology
123
14
bioRxiv

Human Genes Are In Silico Potential Targets For Rice miRNA

bioRxivJanuary 2, 2020
Anatoliy IvashchenkoDana Aisina
10
Oxidative Medicine and Cellular Longevity

The Oxidative Stress-Induced miR-200c Is Upregulated in Psoriasis and Correlates with Disease Severity and Determinants of Cardiovascular Risk

Oxidative Medicine and Cellular LongevityJanuary 14, 2020
A MagentaG Melillo
Nucleic Acid Therapeutics

RNA Interference for the Masses? siRNA Targeting PCSK9 Promises Prevention of Cardiovascular Disease

Nucleic Acid TherapeuticsJanuary 14, 2020
Jonathan K Watts, Ira S Ockene
12
Journal of Clinical Medicine

MicroRNAs as Therapeutic Targets and Clinical Biomarkers in Atherosclerosis

Journal of Clinical MedicineDecember 19, 2019
Emma L SollyJoanne T M Tan
International Journal of Molecular Sciences

Evaluation of Vascular Endothelial Function in Young and Middle-Aged Women with Respect to a History of Pregnancy, Pregnancy-Related Complications, Classical Cardiovascular Risk Factors, and Epigenetics

International Journal of Molecular SciencesJanuary 16, 2020
Ilona HromadnikovaLadislav Krofta
International Journal of Molecular Sciences

Integrated Transcriptomics, Metabolomics, and Lipidomics Profiling in Rat Lung, Blood, and Serum for Assessment of Laser Printer-Emitted Nanoparticle Inhalation Exposure-Induced Disease Risks

International Journal of Molecular SciencesJanuary 1, 2020
Nancy Lan GuoPhilip Demokritou
International Journal of Molecular Medicine

miR‑20b inhibits the senescence of human umbilical vein endothelial cells through regulating the Wnt/β‑catenin pathway via the TXNIP/NLRP3 axis

International Journal of Molecular MedicineJanuary 11, 2020
Feifei DongXianxian Zhao
1
Arteriosclerosis, Thrombosis, and Vascular Biology

Noncoding RNAs in Critical Limb Ischemia

Arteriosclerosis, Thrombosis, and Vascular BiologyJanuary 3, 2020
Daniel Pérez-CremadesMark W Feinberg
International Journal of Clinical and Experimental Pathology

miR-3646 promotes vascular inflammation and augments vascular smooth muscle cell proliferation and migration in progression of coronary artery disease by directly targeting RHOH

International Journal of Clinical and Experimental PathologyJanuary 18, 2020
Xiaoli KangXiaoming Shang
International Journal of Molecular Sciences

Oxidative Stress-Responsive MicroRNAs in Heart Injury

International Journal of Molecular SciencesJanuary 18, 2020
Branislav KuraJan Slezak
Avicenna Journal of Phytomedicine

Does p-coumaric acid improve cardiac injury following LPS-induced lung inflammation through miRNA-146a activity?

Avicenna Journal of PhytomedicineJanuary 11, 2020
Maryam KheiryVahid Bayati
European Journal of Medicinal Chemistry

A review of currently identified small molecule modulators of microRNA function

European Journal of Medicinal ChemistryJanuary 14, 2020
Emile N Van MeterKelly A Teske
2
Journal of Pineal Research

Melatonin alleviates vascular calcification and ageing through exosomal miR-204/miR-211 cluster in a paracrine manner

Journal of Pineal ResearchJanuary 17, 2020
Feng XuLing-Qing Yuan
Indian Journal of Cardiovascular Disease in Women WINCARS

Cardiac Biomarkers: What Is and What Can Be

Indian Journal of Cardiovascular Disease in Women WINCARSJanuary 15, 2020
Rachel Jacob, Mahmood Khan
Current Neurovascular Research

MicroRNA-16-5p aggravates myocardial infarction injury by targeting expression of insulin receptor substrates 1 and mediating myocardial apoptosis and angiogenesis

Current Neurovascular ResearchDecember 25, 2019
Xiancan WangLong Cheng
1
Cardiovascular Diabetology

Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels

Cardiovascular DiabetologyJanuary 9, 2020
William A E ParkerRamzi A Ajjan
4
Arteriosclerosis, Thrombosis, and Vascular Biology

MicroRNA-144 Silencing Protects Against Atherosclerosis in Male, but Not Female Mice

Arteriosclerosis, Thrombosis, and Vascular BiologyDecember 20, 2019
Joan ChengThomas Q de Aguiar Vallim
2
Journal of Cardiothoracic and Vascular Anesthesia

Cardiovascular Risk Assessment for Noncardiac Surgery: Are We Ready for Biomarkers?

Journal of Cardiothoracic and Vascular AnesthesiaDecember 24, 2019
Shalini Dhir, Achal Dhir
2
Journal of Lipid Research

Role of angiopoietin-like protein 3 in sugar-induced dyslipidemia in rhesus macaques: suppression by fish oil or RNAi

Journal of Lipid ResearchJanuary 11, 2020
Andrew A ButlerPeter J Havel
1

See more papers from this feed

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

© 2020 Meta ULC. All rights reserved
/feed-previews/mirnas-in-cardiovascular-biology/93b5f618-03e6-4a05-937c-b49ef4db2578